[250 Pages Report] The Travel Vaccines Market is estimated to reach US$ 3,878.94 Million in 2022. As per the report, sales are forecast to increase at a robust 9.8% CAGR, with the market valuation reaching US$ 6,914.22 Million by 2032.
| Attribute | Details |
|---|---|
| Travel Vaccines Market Estimated Size (2022) | US$ 3,878.94 Million |
| Travel Vaccines Market Projected Size (2032) | US$ 6,914.22 Million |
| Travel Vaccines Market Value-based CAGR (2022 to 2032) | 9.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Vaccines are made up of deceased microbes, living attenuated organisms, or living fully pathogenic organisms that are tested with the purpose of artificially enhancing or generating immunity to a certain disease. The first step towards safe and healthy travel is to get a travel vaccine. Travel vaccine shots, in addition to a passport, are now required before embarking on overseas travel. Travel vaccines give immunisation by lowering the likelihood of becoming ill while travelling overseas.
The growth in the number of travellers and the frequency with which they travel have had medical, epidemiological, and medico-legal effects in addition to economic, cultural, and social ramifications. While travel can be entertaining and thrilling, as well as beneficial to one's mental and physical well-being, it can also be destructive to one's health. Every year, almost 900 million foreign journeys are made. This kind of global travel exposes many people to a variety of health hazards. The growth in worldwide travel has resulted in more frequent illnesses while travelling as well as cases of the disease being imported back to the nation of origin.
This has increased the awareness among several nations and their travellers too. More travellers are getting vaccinated before their trips which proves to be beneficial for the Travel Vaccines Market.
There are several government bodies in different countries, making it mandatory for travelers to be vaccinated before their travel. These countries aim to prevent the entry of diseases from other parts of the world to ensure the safety and well-being of their residents. They provide complete information about the vaccines associated with the diseases and the destinations as well.
These organizations also provide free vaccines for some diseases which are aided by government programs and schemes. This has resulted in increased use of vaccinations by travelers, hence growth in the travel vaccines market.
Principal Consultant
There has been a rapid increase in travel and tourism since the regulations of the pandemic have eased up. People are getting out to explore new places and experiences. Every sector of tourism is getting back to normal and is set to break previous travel records. This has given rise to more people getting vaccinated before their travel as most countries have made vaccinations compulsory for their visitors as well as their residents. As a result, there is an increased demand for vaccines which is expected to boost the Travel Vaccines Market.
Since the pandemic, people all over the world are getting more and more concerned about their health. They are finding new ways to stay immune to diseases and ensure safety during their travel. Government bodies and pharmaceutical companies are taking combined efforts to make different travel vaccines available to travelers. The players are also engaged in research and development to provide vaccines with lesser side effects and minimum dosages. This has helped the travel vaccines market to grow to a large extent. Travelers are getting inclined toward the use of vaccines which will aid the growth of the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Indonesia found a new vaccine for dengue
Takeda's dengue fever vaccine received its long-awaited initial approval after more than a decade of development. After years of testing in Asia and Latin America, authorities in Indonesia approved the vaccination for people aged 6 to 45.
A few processes must be accomplished before the company can distribute the shot. Takeda's contract manufacturer in Germany has a ready-to-ship inventory. Takeda anticipates receiving further clearances in the near future. The corporation is pursuing simultaneous approvals in numerous endemic nations as part of an ambitious regulatory approach. At the same time, European Medicines Agency authorities are reviewing the shot.
Europe invented a novel vaccine to treat multiple diseases
Marketing Authorization was granted by the European Commission (EC) for HEPLISAV B, a vaccine created for the immunization of the infection caused by hepatitis B virus and other varieties of hepatitis B virus in people of age 18 and more, according to Dyanavax, a biopharmaceutical company focused on developing and commercializing novel vaccines. The mandate was granted following the positive judgment of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) on the company's Marketing Authorization Application. The mandate and CHMP recommendation were decided on the good benefit-risk profile of HEPLISAV B, as proven by the findings of three clinical trials of three phases on safety and immunogenicity.
India and China are leading producers of Covid-19 Vaccines
In China and India, two COVID-19 vaccinations given orally or through the nasal cavity have been provided with a green light for use. China's new vaccine is inhaled as an aerosolized mist through the nose and mouth, whereas India's is administered as nasal drops. These mucosal vaccinations are designed to attack the thin membranes that are inside the nose, mouth, and lungs. Mucosal vaccines, by inducing immune responses where the virus enters the body’s system, could prevent even mild episodes of sickness and prevent transmission to others. Some covid doses were proven to be incompetent. Vaccines that produce sterilizing immunity could change the course of the epidemic.
People are afraid of getting infected by corona
Covid-19 vaccines are the most opted vaccines as the disease gave rise to a pandemic and people are more concerned about getting infected by this virus. While countries throughout the world are taking extra efforts to make their territory corona free by making the vaccination mandatory to cross borders.
Online Booking is More Preferred by Tourists
Most travelers prefer booking their vaccination slots in person as visiting the place gives a more clear idea about the vaccines needed as per the travel destination. Travelers are able to choose the vaccinations according to their needs and preferences.
Children and Old people are more susceptible to diseases
Generally, children and senior citizens are more susceptible to getting ill during travel due to the changing climatic and environmental conditions. Hence, the age group 0-14 Years, 56-65 Years, and 66-75 Years are more likely to get vaccinated before their travel.
Several large pharmaceutical companies are conducting research and development for travel vaccines. Travel vaccinations for region-specific diseases are being developed by companies. As the world moves toward free trade and globalization, the number of international tourists is expected to grow year after year. The companies are trying to innovate the vaccines, either by combinations of different vaccines or by reducing the dosages. This will aid in minimizing the side effects caused by the vaccinations and provide immunity against a variety of diseases.
For Instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania & MEA |
| Key Countries Covered | United States of America, Canada, Brazil, Mexico, Argentina, Colombia Germany, UK, France, Italy, Russia, South Africa, Turkey, UAE, Egypt, Jordan China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Philippines, Cambodia, Vietnam Australia & New Zealand. |
| Key Segments Covered | Disease Type, Booking channel, tourist type, tour type, and Region. |
| Key Companies Profiled |
GlaxoSmithKline plc; Merck & Co.; Sanofi; Novartis AG; Pfizer Inc.; Dynavax Technologies; Emergent BioSolutions Inc.; Abbott; Bharat Biotech; Serum Institute of India; Takeda; Chiron; BioNTech; Astra Zeneka; GSK Vaccines; Moderna |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The current Travel Vaccines market has reached valuation of US$ 3,878.94 Million in 2022.
The Travel Vaccines market is currently forecasted to grow at a rate of 9.8% CAGR during the forecast period.
Leading players in Travel Vaccines market are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi, Novartis AG, Pfizer Inc., Dynavax Technologies, Emergent BioSolutions Inc., Abbott, Bharat Biotech among others.
1. Executive Summary | Travel Vaccines Market 1.1. Global Market Outlook 1.1.1. Who Is Travelling? 1.1.2. How Much Do They Spend? 1.1.3. Direct Contribution of Tourism To GDP 1.1.4. Direct Contribution of Tourism To Employment 1.2. Tourism Evolution Analysis 1.3. FMI Analysis and Recommendations 2. Market Introduction 2.1. Total Spending (US$ Million) and Forecast (2022 to 2032) 2.2. Number of Travelers (Million) and Forecast (2022 to 2032) 2.3. Total Spending Y-o-Y Growth Projections (2022 to 2032) 2.4. Number of Travelers Y-o-Y Growth Projections 3. Global Tourism Industry Analysis 3.1. Tourism Industry Overview 3.1.1. Travel & Tourism Industry Contribution To Global GDP 3.1.1.1. Business Spending v/s Leisure Spending 3.1.1.2. Domestic v/s Foreign 3.1.1.3. Direct, Indirect, and Induced 3.1.2. Travel Sector Contribution To Global Overall Employment 3.1.3. Travel & Tourism Growth Rate 3.1.4. Foreign Visitor Exports As Percentage of Total Exports 3.1.5. Capital Investment In Travel & Tourism Industry 3.1.6. Different Components of Travel & Tourism 3.1.7. Global Tourism Industry Outlook 3.1.7.1. Cultural Tourism 3.1.7.2. Culinary Tourism 3.1.7.3. Eco/Sustainable Tourism 3.1.7.4. Sports Tourism 3.1.7.5. Spiritual Tourism 3.1.7.6. Wellness Tourism 3.1.7.7. Others 4. Market Dynamics 4.1. Market Drivers & Opportunities 4.1.1. Increase in travel and tourism 4.1.2. Growing incidences of infectious diseases 4.1.3. Increasing awareness 5. Market Background 5.1. Top 10 Market Companies 5.2. Macro-Economic Factors 5.2.1. Global GDP Growth Outlook 5.2.2. Global Industry Value Added 5.2.3. Global Consumer Spending Outlook 5.2.4. Global Direct contribution of Travel & Tourism to GDP 5.2.5. Global Visitor Exports and International Tourist Arrivals 5.2.6. Capital Investment In Travel & Tourism 5.2.7. Top Tourism Spending Countries 5.3. Forecast Factors - Relevance & Impact 6. Categorizing of Sector 2021 6.1. Introduction/ Key Findings 6.2. Current Market Analysis By disease type (% of Demand) 6.2.1. Covid-19 6.2.2. Ebola 6.2.3. Influenza 6.2.4. Hepatitis 6.2.5. Others 6.3. Current Market Analysis By Booking Channel (% of Demand) 6.3.1. Online Booking 6.3.2. Direct Booking 6.4. Current Market Analysis By Tourist Type (% of Demand) 6.4.1. Domestic 6.4.2. International 6.5. Current Market Analysis By Tour Type (% of Demand) 6.5.1. Independent Traveller 6.5.2. Tour Group 6.5.3. Package Traveller 6.6. Current Market Analysis By Age Group (% of Demand) 6.6.1. 15-25 Years 6.6.2. 26-35 Years 6.6.3. 36-45 Years 6.6.4. 46-55 Years 6.6.5. 56-65 Years 6.6.6. 66-75 Years 6.7. Current Market Analysis By Region (% of Demand) 6.7.1. North America 6.7.2. Latin America 6.7.3. Europe 6.7.4. East Asia 6.7.5. South Asia 6.7.6. Oceania 6.7.7. Middle East and Africa (MEA) 6.8. Key Findings, By Each Category 7. Categorizing of North America Sector 2021 7.1. Introduction/ Key Findings 7.2. Current Market Analysis By disease type (% of Demand) 7.2.1. Covid-19 7.2.2. Ebola 7.2.3. Influenza 7.2.4. Hepatitis 7.2.5. Others 7.3. Current Market Analysis By Booking Channel (% of Demand) 7.3.1. Online Booking 7.3.2. Direct Booking 7.4. Current Market Analysis By Tourist Type (% of Demand) 7.4.1. Domestic 7.4.2. International 7.5. Current Market Analysis By Tour Type (% of Demand) 7.5.1. Independent Traveller 7.5.2. Tour Group 7.5.3. Package Traveller 7.6. Current Market Analysis By Age Group (% of Demand) 7.6.1. 15-25 Years 7.6.2. 26-35 Years 7.6.3. 36-45 Years 7.6.4. 46-55 Years 7.6.5. 56-65 Years 7.6.6. 66-75 Years 7.7. Current Market Analysis By Country (% of Demand) 7.7.1. US 7.7.2. Canada 7.8. Key Findings, By Each Category 8. Categorizing of Latin America Sector 2021 8.1. Introduction/ Key Findings 8.2. Current Market Analysis By disease type (% of Demand) 8.2.1. Covid-19 8.2.2. Ebola 8.2.3. Influenza 8.2.4. Hepatitis 8.2.5. Others 8.3. Current Market Analysis By Booking Channel (% of Demand) 8.3.1. Online Booking 8.3.2. Direct Booking 8.4. Current Market Analysis By Tourist Type (% of Demand) 8.4.1. Domestic 8.4.2. International 8.5. Current Market Analysis By Tour Type (% of Demand) 8.5.1. Independent Traveller 8.5.2. Tour Group 8.5.3. Package Traveller 8.6. Current Market Analysis By Age Group (% of Demand) 8.6.1. 15-25 Years 8.6.2. 26-35 Years 8.6.3. 36-45 Years 8.6.4. 46-55 Years 8.6.5. 56-65 Years 8.6.6. 66-75 Years 8.7. Current Market Analysis By Country (% of Demand) 8.7.1. Brazil 8.7.2. Mexico 8.7.3. Argentina 8.7.4. Colombia 8.7.5. Rest of LA 8.8. Key Findings, By Each Category 9. Categorizing of Europe Sector 2021 9.1. Introduction/ Key Findings 9.2. Current Market Analysis By disease type (% of Demand) 9.2.1. Covid-19 9.2.2. Ebola 9.2.3. Influenza 9.2.4. Hepatitis 9.2.5. Others 9.3. Current Market Analysis By Booking Channel (% of Demand) 9.3.1. Online Booking 9.3.2. Direct Booking 9.4. Current Market Analysis By Tourist Type (% of Demand) 9.4.1. Domestic 9.4.2. International 9.5. Current Market Analysis By Tour Type (% of Demand) 9.5.1. Independent Traveller 9.5.2. Tour Group 9.5.3. Package Traveller 9.6. Current Market Analysis By Age Group (% of Demand) 9.6.1. 15-25 Years 9.6.2. 26-35 Years 9.6.3. 36-45 Years 9.6.4. 46-55 Years 9.6.5. 56-65 Years 9.6.6. 66-75 Years 9.7. Current Market Analysis By Country (% of Demand) 9.7.1. Germany 9.7.2. Russia 9.7.3. France 9.7.4. Italy 9.7.5. UK 9.7.6. Rest of Europe 9.8. Key Findings, By Each Category 10. Categorizing of East Asia Sector 2021 10.1. Introduction/ Key Findings 10.2. Current Market Analysis By disease type (% of Demand) 10.2.1. Covid-19 10.2.2. Ebola 10.2.3. Influenza 10.2.4. Hepatitis 10.2.5. Others 10.3. Current Market Analysis By Booking Channel (% of Demand) 10.3.1. Online Booking 10.3.2. Direct Booking 10.4. Current Market Analysis By Tourist Type (% of Demand) 10.4.1. Domestic 10.4.2. International 10.5. Current Market Analysis By Tour Type (% of Demand) 10.5.1. Independent Traveller 10.5.2. Tour Group 10.5.3. Package Traveller 10.6. Current Market Analysis By Age Group (% of Demand) 10.6.1. 15-25 Years 10.6.2. 26-35 Years 10.6.3. 36-45 Years 10.6.4. 46-55 Years 10.6.5. 56-65 Years 10.6.6. 66-75 Years 10.7. Current Market Analysis By Country (% of Demand) 10.7.1. China 10.7.2. Japan 10.7.3. South Korea 10.8. Key Findings, By Each Category 11. Categorizing of South Asia Sector 2021 11.1. Introduction/ Key Findings 11.2. Current Market Analysis By disease type (% of Demand) 11.2.1. Covid-19 11.2.2. Ebola 11.2.3. Influenza 11.2.4. Hepatitis 11.2.5. Others 11.3. Current Market Analysis By Booking Channel (% of Demand) 11.3.1. Online Booking 11.3.2. Direct Booking 11.4. Current Market Analysis By Tourist Type (% of Demand) 11.4.1. Domestic 11.4.2. International 11.5. Current Market Analysis By Tour Type (% of Demand) 11.5.1. Independent Traveller 11.5.2. Tour Group 11.5.3. Package Traveller 11.6. Current Market Analysis By Age Group (% of Demand) 11.6.1. 15-25 Years 11.6.2. 26-35 Years 11.6.3. 36-45 Years 11.6.4. 46-55 Years 11.6.5. 56-65 Years 11.6.6. 66-75 Years 11.7. Current Market Analysis By Country (% of Demand) 11.7.1. India 11.7.2. Malaysia 11.7.3. Indonesia 11.7.4. Thailand 11.7.5. Philippines 11.7.6. Cambodia 11.7.7. Vietnam 11.7.8. Rest of SA 11.8. Key Findings, By Each Category 12. Categorizing of Oceania Sector 2021 12.1. Introduction/ Key Findings 12.2. Current Market Analysis By disease type (% of Demand) 12.2.1. Covid-19 12.2.2. Ebola 12.2.3. Influenza 12.2.4. Hepatitis 12.2.5. Others 12.3. Current Market Analysis By Booking Channel (% of Demand) 12.3.1. Online Booking 12.3.2. Direct Booking 12.4. Current Market Analysis By Tourist Type (% of Demand) 12.4.1. Domestic 12.4.2. International 12.5. Current Market Analysis By Tour Type (% of Demand) 12.5.1. Independent Traveller 12.5.2. Tour Group 12.5.3. Package Traveller 12.6. Current Market Analysis By Age Group (% of Demand) 12.6.1. 15-25 Years 12.6.2. 26-35 Years 12.6.3. 36-45 Years 12.6.4. 46-55 Years 12.6.5. 56-65 Years 12.6.6. 66-75 Years 12.7. Current Market Analysis By Country (% of Demand) 12.7.1. Australia 12.7.2. New Zealand 12.8. Key Findings, By Each Category 13. Categorizing of Middle East and Africa Sector 2021 13.1. Introduction/ Key Findings 13.2. Current Market Analysis disease type (% of Demand) 13.2.1. Covid-19 13.2.2. Ebola 13.2.3. Influenza 13.2.4. Hepatitis 13.2.5. Others 13.3. Current Market Analysis By Booking Channel (% of Demand) 13.3.1. Online Booking 13.3.2. Direct Booking 13.4. Current Market Analysis By Tourist Type (% of Demand) 13.4.1. Domestic 13.4.2. International 13.5. Current Market Analysis By Tour Type (% of Demand) 13.5.1. Independent Traveller 13.5.2. Tour Group 13.5.3. Package Traveller 13.6. Current Market Analysis By Age Group (% of Demand) 13.6.1. 15-25 Years 13.6.2. 26-35 Years 13.6.3. 36-45 Years 13.6.4. 46-55 Years 13.6.5. 56-65 Years 13.6.6. 66-75 Years 13.7. Current Market Analysis By Country (% of Demand) 13.7.1. Turkey 13.7.2. South Africa 13.7.3. UAE 13.7.4. Egypt 13.7.5. Jordan 13.7.6. Rest of MEA 13.8. Key Findings, By Each Category 14. Competition Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Competition Deep Dive 14.3.1. GlaxoSmithKline plc 14.3.1.1. Overview 14.3.1.2. Service Portfolio 14.3.1.3. Strategy Overview/campaigns 14.3.2. Merck & Co. 14.3.2.1. Overview 14.3.2.2. Service Portfolio 14.3.2.3. Strategy Overview/campaigns 14.3.3. Sanofi 14.3.3.1. Overview 14.3.3.2. Service Portfolio 14.3.3.3. Strategy Overview/campaigns 14.3.4. Novartis AG 14.3.4.1. Overview 14.3.4.2. Service Portfolio 14.3.4.3. Strategy Overview/campaigns 14.3.5. Pfizer Inc. 14.3.5.1. Overview 14.3.5.2. Service Portfolio 14.3.5.3. Strategy Overview/campaigns 14.3.6. Dynavax Technologies 14.3.6.1. Overview 14.3.6.2. Service Portfolio 14.3.6.3. Strategy Overview/campaigns 14.3.7. Emergent BioSolutions Inc. 14.3.7.1. Overview 14.3.7.2. Service Portfolio 14.3.7.3. Strategy Overview/campaigns 14.3.8. Abbott 14.3.8.1. Overview 14.3.8.2. Service Portfolio 14.3.8.3. Strategy Overview/campaigns 14.3.9. Bharat Biotech 14.3.9.1. Overview 14.3.9.2. Service Portfolio 14.3.9.3. Strategy Overview/campaigns 14.3.10. Serum Institute of India 14.3.10.1. Overview 14.3.10.2. Service Portfolio 14.3.10.3. Strategy Overview/campaigns 14.3.11. Takeda 14.3.11.1. Overview 14.3.11.2. Service Portfolio 14.3.11.3. Strategy Overview/campaigns 14.3.12. Chiron 14.3.12.1. Overview 14.3.12.2. Service Portfolio 14.3.12.3. Strategy Overview/campaigns 14.3.13. BioNTech 14.3.13.1. Overview 14.3.13.2. Service Portfolio 14.3.13.3. Strategy Overview/campaigns 14.3.14. Astra Zeneka 14.3.14.1. Overview 14.3.14.2. Service Portfolio 14.3.14.3. Strategy Overview/campaigns 14.3.15. GSK Vaccines 14.3.15.1. Overview 14.3.15.2. Service Portfolio 14.3.15.3. Strategy Overview/campaigns 14.3.16. Moderna 14.3.16.1. Overview 14.3.16.2. Service Portfolio 14.3.16.3. Strategy Overview/campaigns 14.4. Social Media Platforms Preferred 14.4.1. Facebook 14.4.2. YouTube 14.4.3. Instagram 14.4.4. Twitter 14.4.5. LinkedIn 14.4.6. Pinterest 14.4.7. Google+ 14.4.8. Others 14.5. Perceptions of the Proposed Art Sector Tour Package 14.6. Consumer Perception for Destinations On Social Media Platforms-Positive and Negative Mentions 14.7. Trending #Hashtags 14.8. Social Media Platform Mentions (% of Total Mentions) 14.9. Region-Wise Social Media Mentions (% of Total Mentions) 14.10. Trending Subject Titles 15. Assumptions and Acronyms Used 16. Research Methodology
Explore Travel and Tourism Insights
View Reports
Travel Vaccines Market
